Adenovirus vectors containing cell status-specific response elements and methods of use thereof
View Patent ↗The present invention provides adenoviral vectors comprising cell status-specific transcriptional regulatory elements which confer cell status-specific transcriptional regulation on an adenoviral gene. A “cell status” is generally a reversible physiological and/or environmental state. The invention further provides compositions and host cells comprising the vectors, as well as methods of using the vectors.
1. A replication-competent adenovirus vector for selective cytolysis of a cancer target cell comprising an adenovirus gene essential for replication selected from the group consisting of E1A, E1B, and E4, operably linked to both of (1) a cell status-specific transcriptional response element (TRE), wherein the cell status-specific TRE comprises the E2F-1 TRE nucleotides presented as SEQ ID NO:1 and (2) a cell-type specific TRE, wherein the cell-type specific TRE is a PSA-TRE comprising nucleotides about 503 to about 2086 of SEQ ID NO:2 and nucleotides about 5285 to about 5836 of SEQ ID NO:2.
2. The adenovirus vector of claim 1 , wherein said vector further comprises a deletion in E3.
3. The adenovirus vector of claim 1 , further comprising a transgene operably linked to the E2F-1 nucleotides presented as SEQ ID NO:1, wherein the transgene encodes ADP having the sequence presented as SEQ ID NO:8.
4. A composition comprising the replication-competent adenovirus vector of claim 1 and a pharmaceutically acceptable excipient.
5. An isolated host cell comprising the adenovirus vector of claim 1 .